QDHC Quadramed Corp (MM)

QuadraMed (NASDAQ:QDHC) today announced that Los Altos Hills, Calif.,-based Daughters of Charity Health System (DCHS) has signed a $15.8 million contract to expand the use of QuadraMed CPR (QCPR) across its five-hospital network. With this contract, DCHS has purchased software and services for the QCPR platform including interactive care-grid, order management, access management, clinical decision support, nursing documentation, chart management and additional software for scheduling, electronic document management, medical records, computerized physician order entry and patient registration. This new agreement is in addition to the $6.7 million, initial Phase 1 agreement for the QCPR integrated medication management system, which was originally finalized on Nov. 30, 2006. �After conducting a thorough evaluation, we determined that QuadraMed was the ideal partner to help us realize our vision of deploying a comprehensive electronic health record while seamlessly integrating and driving best practices throughout our organization,� said Richard Hutsell, DCHS�s vice president and CIO. �QuadraMed's commitment to enhancing the QCPR platform and their ability to deliver a full, end-to-end, integrated solution over time were key factors in our decision. We continue to be quite pleased with how QuadraMed has assumed responsibility for QCPR.� DCHS was originally a client of Misys Healthcare Systems (�Misys�); however, DCHS recognized the significant value offered by QuadraMed following its acquisition of the Misys CPR product in 2007. Specifically, the hospital system understood that QuadraMed's ongoing product innovation and superior client support were important elements to achieving improved patient safety and quality care. Additionally, they acknowledged the importance of streamlining administrative functions to optimize organizational revenue through QuadraMed's enterprise care management system. As such, DCHS has standardized on QCPR for their electronic health record platform. �We�re delighted to be DCHS� vendor of choice,� said Keith Hagen, QuadraMed�s president and CEO. �This win adds to the growing success we have experienced in the market place and validates our QCPR strategy and acquisition decision. I am pleased to say that we have now signed contracts for QCPR that have a cumulative total contract value well in excess of the $33M we paid for that business just 10 months ago.� About Daughters of Charity Health System Los Altos Hills, Calif.-based Daughters of Charity Health System (DCHS) is a regional healthcare system of five hospitals spanning the California coast from the Bay Area to Los Angeles. Our sponsors are the Daughters of Charity of St. Vincent de Paul who, for more than 370 years, have been serving the sick and the poor through healing ministries around the world. For more information about DCHS, visit http://www.dochs.org/Pages/Default.aspx. About QuadraMed Corporation QuadraMed Corporation advances the success of healthcare organizations through IT solutions that leverage quality care into positive financial outcomes. QuadraMed provides real world solutions that help healthcare professionals deliver outstanding patient care efficiently and cost effectively. Behind the company�s products and services is a staff of 650 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit http://www.quadramed.com/ Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 by QuadraMed that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed�s actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed�s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC�s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833). QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.